ResMed

The Next Generation in Bilevel Therapy Now Available on ResMed's Award-Winning S9(TM) Platform

Oslo, Norway (ots/PRNewswire) - ResMed , a leading developer, manufacturer, and distributor of sleep and respiratory medical equipment, announced the launch of its next generation bilevel therapy devices.

"We are proud to announce the launch of the bilevel range of products on the S9(TM) platform, our latest and most innovative flow generator system for treating respiratory disorders including sleep-disordered breathing (SDB). Now, for the first time in our history, patients have one platform that can treat obstructive sleep apnea, central sleep apnea and Cheyne-Stokes respiration as well as provide noninvasive ventilation (NIV) for patients requiring ventilatory support," said Michael Farrell, SVP of the Global Sleep Business Unit at ResMed. "Our goal is to increase patients' quality of life by providing comfortable, quiet, easy-to-use, and highly effective treatment. A critical element of successful treatment is long-term adherence to therapy. Since its launch just over a year ago, the S9 Series has been able to help physicians and respiratory therapists achieve that goal - driving therapeutic compliance by patients around the globe."

Historically, patients' ability to comply with sleep or respiratory therapies was negatively affected by noisy devices, nasal dryness/congestion and breathing discomfort. To combat these negative effects and increase patients' ability to adhere to respiratory therapy, ResMed's next generation bilevel devices build on features that are crucial to maintaining and increasing overall patient compliance.

ResMed's enhanced Easy-Breathe(TM) motor technology reduces noise transferred through the mask to the patient by 78%, compared to the S8(TM) Series II. The improved ClimateControl(TM) system ensures consistent therapeutic air temperature and humidification, working to prevent rain-out and dryness, independent of external ambient conditions. With the integration of ResMed's Vsync(TM), TiControl(TM), and Easy-Breath waveform technologies, each device can now be fine-tuned to synchronise to the specific needs of each individual patient. Finally, patient data can now be accessed via the easy-to-use color screen or can be downloaded in high resolution and viewed in ResMed's ResScan(TM) software.

"We remain focused on providing best in class NIV solutions; now delivering NIV therapy by way of a smaller, lighter, and quieter platform. The VPAP ST offers unmatched therapy performance to a broader range of patients through the enhancements of our clinically proven synchronisation algorithms, Vsync and TiControl alongside Climate Control and a higher backup rate," said Geoff Neilson, Vice President - Ventilation Strategic Business Unit.

ResMed's new pressure support bilevel devices include the VPAP(TM) S, a bilevel pressure support therapy device; the Auto 25, an auto-adjusting bilevel therapy device; the AutoSet CS(TM), the adaptive servo-ventilation therapy device; and the VPAP(TM) ST, a noninvasive pressure support ventilator. All four devices are built to meet the highest standard of effective therapy, comfortable treatment, and ease of use.

For additional product information visit http://www.resmed.com

About ResMed

ResMed is a leading developer, manufacturer, and distributor of medical equipment for treating, diagnosing, and managing sleep-disordered breathing and other respiratory disorders. We are dedicated to developing innovative products to improve the lives of those who suffer from these conditions and to increasing awareness among patients and healthcare professionals of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit http://www.resmed.com

Contact ResMed: Henrik Aase Marketing Communications Director - Europe Office: +47-67-11-88-59 | Mobile: +47-97-53-91-12 henrik.aase@resmed.com For interviews, photos, additional info: Rikke Eckhoff, Burson-Marsteller Oslo Mobile : +47-990-82-202 rikke.eckhoff@bm.com

Contact:

Contact ResMed: Henrik Aase, Marketing Communications Director
-Europe, Office: +47-67-11-88-59 | Mobile:
+47-97-53-91-12,henrik.aase@resmed.com; For interviews, photos,
additional info: RikkeEckhoff, Burson-Marsteller Oslo, Mobile :
+47-990-82-202,rikke.eckhoff@bm.com



Weitere Meldungen: ResMed

Das könnte Sie auch interessieren: